ASHP Guidelines on Preventing Diversion of Controlled Substances.

Autor: Brummond PW; Froedtert & The Medical College of Wisconsin, Milwaukee, WI., Chen DF; ASHP, Bethesda, MD., Churchill WW; Brigham and Women's Healthcare, Boston, MA., Clark JS; University of Michigan Hospitals and Health Centers, Ann Arbor, MI., Dillon KR; Mayo Clinic, Rochester, MN., Dumitru D; BD Dispensing Technologies & Solutions, San Diego, CA., Eschenbacher L; The Resource Group (Ascension), St. Louis, MO., Fera T; Carnegie, PA., Fortier CR; Massachusetts General Hospital, Boston, MA., Gullickson KK; Abbott Northwestern Hospital, Allina Health, Minneapolis, MN., Jurakovich K; University of Wisconsin Health, Madison, WI., Kent S; University of Michigan Hospitals and Health Centers, University of Michigan College of Pharmacy, Ann Arbor, MI., Keonavong J; Banner Pharmacy Services, Phoenix, AZ., Marchese C; Rhode Island and Hasbro Children's Hospital, Providence, RI., Meyer T; Baylor Scott and White Medical Center, Temple, TX., Murdaugh LB; Cardinal Health Innovative Delivery Solutions, Knoxville, TN., Ogden RK Jr; Children's Mercy Hospital, Kansas City, MO., O'Neal BC; Children's Mercy Kansas City, Kansas City, MO., Rough S; University of Wisconsin Health, Madison, WI., Saenz R; University of Virginia Health System, Charlottesville, VA., Smith JS; The Johns Hopkins Health System, Baltimore, MD.

Publikováno v: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2017 Mar 01; Vol. 74 (5), pp. 325-348. Date of Electronic Publication: 2017 Jan 04.